Atlas Trials

Clinical Study of Anlotinib in Maintenance Treatment of Advanced NSCLC

Clinical trial NCT03769805 · UNKNOWN

Trial details

NCT number
NCT03769805
Sponsor
The First Affiliated Hospital with Nanjing Medical University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Nonsmall Cell Lung Cancer
Start date
2019-06-15
Primary completion
2020-12-31
Enrollment
83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.